• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND CO. ANTI-KAPPA PE CE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND CO. ANTI-KAPPA PE CE Back to Search Results
Catalog Number 347246
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/11/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that have been found during a field corrective action anti-kappa pe ce contamination with cd8 pe antibody.
 
Manufacturer Narrative
H.6 investigation summary: scope of issue: the scope of issue is limited to catalogue no.Material 347246 batch 1153851, anti kappa pe.Problem statement: customer reported a claim for material 347246 batch 1153851 referencing field corrective action(fca) bdb-22-4384 for anti kappa contamination with cd8 pe.The customer checked analysis performed with this product and confirmed described contamination for analyzed patient samples, but without impact on patient diagnosis and treatment.Manufacturing defect trend: the manufacture trend defect was evaluated for material 347246 in the period of 29jul2022 to 29jul2021 and there is no reported quality notifications for the material in the timeframe evaluated.Batch history record (bhr) review: the bhrs for material 347246 batch 1153851 were evaluated as part of the investigation conducted under bdb-22-4384 and found that the cleaning of a vessel was not documented at the purification phase.Complaint history review: there are two complaints reported for material 347246 after the fca was initiated.Additional claims were evaluated as part of the investigation conducted under bdb-22-4384-sa for other listed catalogue numbers.Retain sample analysis: the retained sample was evaluated as part of the investigation conducted for fca bdb-22-4384 and confirm the event reported on the fca.Returned sample analysis: the sample was not returned but the manufacturing site retained bulk sample was evaluated.Labeling /packaging review: n/a.Risk review: fmea anti-kappa revision 3 was reviewed.Hazard(s) identified? yes, section 2: not perform to spec/claim.Potential function failure: section 2: not perform to spec/claim.Potential effect of failure: 3.Wrong result.¿ no matching profile.-customer inconveniences -additional testing, cost and time.Potential cause of failure: 10.Chemistry bulk contamination with another reagent.Severity: 7.Occurrence : 1.Detection : 8.Risk control: 1.Column stripping procedures, 2.Process segregation.3.Use of clean apparatus - validated washing processes.4.Physical testing in qc ref vs test.Rpn:56 rpn < 90 will be acceptable.New hazard: none.Mitigation(s) sufficient x: yes / no.The risk was analyzed as part of the bdb-22-4384 -hra and a field action initiated.Root cause analysis: based on the investigation result, root cause was the use of an uncleaned vessel at the purification stage.Conclusion: based on the investigation result, complaint was confirmed and the customer was notified as part of the actions taken under field corrective action bdb-22-4384.
 
Event Description
It was reported that have been found during a field corrective action anti-kappa pe ce contamination with cd8 pe antibody.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANTI-KAPPA PE CE
Type of Device
NA
Manufacturer (Section D)
BECTON, DICKINSON AND CO.
10865 road to the cure
suite no. 210
san diego CA 92121
Manufacturer (Section G)
BECTON, DICKINSON AND CO.
10865 road to the cure
suite no. 210
san diego CA 92121
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15196036
MDR Text Key304974407
Report Number3007886372-2022-00002
Device Sequence Number1
Product Code MVU
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date01/31/2023
Device Catalogue Number347246
Device Lot Number1153851
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/21/2022
Initial Date FDA Received08/09/2022
Supplement Dates Manufacturer Received11/23/2022
Supplement Dates FDA Received11/30/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/06/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-